Geode Capital Management LLC boosted its position in shares of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) by 18.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,913,696 shares of the software maker’s stock after purchasing an additional 294,993 shares during the period. Geode Capital Management LLC owned 1.06% of Allscripts Healthcare Solutions worth $27,844,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in MDRX. Nationwide Fund Advisors boosted its position in Allscripts Healthcare Solutions by 18.6% during the third quarter. Nationwide Fund Advisors now owns 539,813 shares of the software maker’s stock valued at $7,682,000 after purchasing an additional 84,636 shares during the last quarter. Crossmark Global Holdings Inc. acquired a new stake in Allscripts Healthcare Solutions during the third quarter valued at $187,000. Principal Financial Group Inc. boosted its position in Allscripts Healthcare Solutions by 30.1% during the third quarter. Principal Financial Group Inc. now owns 1,003,690 shares of the software maker’s stock valued at $14,283,000 after purchasing an additional 232,209 shares during the last quarter. Russell Investments Group Ltd. boosted its position in Allscripts Healthcare Solutions by 34.9% during the third quarter. Russell Investments Group Ltd. now owns 1,196,071 shares of the software maker’s stock valued at $17,020,000 after purchasing an additional 309,337 shares during the last quarter. Finally, Ameriprise Financial Inc. boosted its position in Allscripts Healthcare Solutions by 85.6% during the third quarter. Ameriprise Financial Inc. now owns 952,925 shares of the software maker’s stock valued at $13,559,000 after purchasing an additional 439,489 shares during the last quarter.
In other news, EVP Brian Farley sold 5,000 shares of Allscripts Healthcare Solutions stock in a transaction dated Wednesday, March 14th. The stock was sold at an average price of $13.73, for a total value of $68,650.00. Following the transaction, the executive vice president now directly owns 240,672 shares in the company, valued at $3,304,426.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, President Richard J. Poulton sold 15,000 shares of Allscripts Healthcare Solutions stock in a transaction dated Thursday, March 15th. The stock was sold at an average price of $13.53, for a total value of $202,950.00. Following the completion of the transaction, the president now owns 505,920 shares in the company, valued at $6,845,097.60. The disclosure for this sale can be found here. Insiders own 0.75% of the company’s stock.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its quarterly earnings data on Thursday, February 15th. The software maker reported $0.18 EPS for the quarter, hitting analysts’ consensus estimates of $0.18. The business had revenue of $547.00 million for the quarter, compared to analyst estimates of $524.05 million. Allscripts Healthcare Solutions had a positive return on equity of 7.36% and a negative net margin of 10.88%. The firm’s revenue for the quarter was up 27.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.14 earnings per share. research analysts predict that Allscripts Healthcare Solutions Inc will post 0.56 EPS for the current fiscal year.
A number of analysts recently issued reports on MDRX shares. Cantor Fitzgerald reissued a “buy” rating and set a $17.00 price objective on shares of Allscripts Healthcare Solutions in a research report on Monday, January 8th. Zacks Investment Research cut Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research report on Friday, January 12th. Maxim Group reaffirmed a “buy” rating and issued a $20.00 price target on shares of Allscripts Healthcare Solutions in a research report on Tuesday, January 9th. BidaskClub raised Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating in a research report on Wednesday, December 20th. Finally, Wells Fargo set a $19.00 price target on Allscripts Healthcare Solutions and gave the stock a “buy” rating in a research report on Saturday, February 17th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and eleven have assigned a buy rating to the company. Allscripts Healthcare Solutions has a consensus rating of “Buy” and an average price target of $16.22.
ILLEGAL ACTIVITY NOTICE: This report was first posted by Ticker Report and is the property of of Ticker Report. If you are reading this report on another domain, it was stolen and republished in violation of international copyright law. The original version of this report can be read at https://www.tickerreport.com/banking-finance/3298738/geode-capital-management-llc-grows-position-in-allscripts-healthcare-solutions-inc-mdrx.html.
About Allscripts Healthcare Solutions
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.